glp-1 agonists oral The challenge of developing alternatives to Ozempic, Wegovy and Mounjaro Removing the needle: the unmet

Future Research Directions Novel Therapeutic Targets Emerging therapies targeting endothelial dysfunction, blood-brain barrier repair, inflammation, oxidative stress, and white matter regeneration are under investigation

b) Provider Education Needs : Many primary care physicians report feeling unprepared to effectively manage patients on GLP-1 medications

Email : [email protected] Disclaimers and Affiliate Disclosures General Disclaimer The content presented in this publication is intended for informational and educational purposes only

Raw transcriptomics (1019 cell lines) and metabolomics (225 metabolites, 928 cell line samples) data were downloaded from broadinstitute.org (available at the time of writing via depmap.org/portal/download/)

Long-term studies show maintained weight loss with ongoing GLP-1 therapy over two years and beyond

Becker, A